Prospective Diabetes Registry of Patients With Type 2 Diabetes Mellitus on SGLT 2 Inhibitor Therapy in Singapore

Trial Identifier: D1843R00258
Sponsor: AstraZeneca
NCTID:: NCT02578563
Start Date: February 2016
Primary Completion Date: December 2018
Condition: Endocrine - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Singapore, Singapore Singapore, Singapore